# OnCo record avenger-500 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/avenger-500/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "avenger-500", "NCT03504423" ;
  schema:name "AVENGER 500"@en ;
  schema:description "Adding the metabolism drug devimistat to FOLFIRINOX did not help people with metastatic pancreatic cancer live longer."@en ;
  schema:url <https://onco.cc/trials/avenger-500/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03504423>, <https://doi.org/10.1200/JCO.23.02659> ;
  onco:status "negative" ;
  onco:phase "3" ;
  schema:startDate "2018-11-09" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/devimistat/>, <https://onco.cc/drugs/folfirinox/> ;
  onco:companies <https://onco.cc/companies/cornerstone-pharmaceuticals/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-philip-j-clin-oncol/> .